discontinuing glp 1 Now, a new world-first clinical trial reveals a safe, effective, and long-lasting way to maintain drug-free weight loss after GLP-1 discontinuation The Data Are Clear: Patients

Glucagon-like peptide-1 (GLP-1) receptor agonistsincluding semaglutide (Ozempic, Wegovy), liraglutide (Saxenda, Victoza), and tirzepatide (Mounjaro)are highly effective for glycaemic control and weight reduction, but some individuals experience hair thinning during treatment

The correct approach is 90471 for the first injection, then +90472 for each additional one

Single cell and spatial alternative splicing analysis with Nanopore long read sequencing

Then Dr

Sex-specific impact of major depressive disorder on 12-year change in glycaemic status: results from a nationwide cohort study of adults without diabetes in Germany

10.1038/s41589-020-0529-6 Nat